A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

Summary

The purposes of this study are to compare the effects of Topiramate and placebo on abdominal visceral fat accumulation at 6 months and to evaluate the safety of Topiramate for up to 12 months of continued treatment in male patients with abdominal obesity.

Timeline

Start

1998-12

Primary completion

—

Completion

2002-01

Drugs

Indications